Lei Fan
Lei Fan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Chuangang Zang
Research Office, Qiqihar Medical University, Qiqihar 161006, China
1 shared publication - Fei Huang
PIESAT Information Technology Co, Ltd, Beijing, 100195, China
1 shared publication - Gulian Xing
China Institute of Geological Environment Monitoring, Beijing, 100081, China
1 shared publication - Hao Guo
Research Office, Qiqihar Medical University, Qiqihar 161006, China
1 shared publication - Hong Guan
Research Center of Microecological Engineering Technology, Qiqihar Medical University, Qiqihar, P. R. China
1 shared publication - Hui Yin
School of Management, Hefei University of Technology, Hefei, China
1 shared publication
Latest Publications
- Open Access
- 1 June 2023
- Published by KEAI Publishing in Natural Hazards Research
- Vol. 3 (2) , 155-169
Landslide susceptibility evaluation and interpretability analysis of typical loess areas based on deep learning
- 1 June 2023
- Published by KEAI Publishing in Natural Hazards Research
- Vol. 3 (2) , 155-169
Open AccessLandslide susceptibility evaluation and interpretability analysis of typical loess areas based on deep learning
- Open Access
- 1 January 2023
- Published by Springer Nature in Food Science of Animal Resources
- Vol. 43 (1) , 10-24
Separation and Purification of Antioxidant Peptide from Fermented Whey Protein by Lactobacillus rhamnosus B2-1
Food Science of Animal Resources (Food Sci. Anim. Resour.) is an international, peer-reviewed bimonthly journal publishing original research and reviews on basic and applied aspects of the use of animal resources including the meat, egg, dairy, and edible insect/worm products. Food Sci. Anim. Resour. is published and distributed by the Korean Society for Food Science of Animal Resources.
- 1 January 2023
- Published by Springer Nature in Food Science of Animal Resources
- Vol. 43 (1) , 10-24
Open AccessSeparation and Purification of Antioxidant Peptide from Fermented Whey Protein by Lactobacillus rhamnosus B2-1
Food Science of Animal Resources (Food Sci. Anim. Resour.) is an international, peer-reviewed bimonthly journal publishing original research and reviews on basic and applied aspects of the use of animal resources including the meat, egg, dairy, and edible insect/worm products. Food Sci. Anim. Resour. is published and distributed by the Korean Society for Food Science of Animal Resources.
- 28 November 2022
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 633, 657-667
CaCO3-assistant synthesis of pH/near-infrared light-responsive and injectable sodium alginate hydrogels for melanoma synergistic treatment
- 28 November 2022
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 633, 657-667
CaCO3-assistant synthesis of pH/near-infrared light-responsive and injectable sodium alginate hydrogels for melanoma synergistic treatment
- Open Access
- 1 July 2022
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 11 (7) , 2382-2394
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis
Background: Long-term benefit of nanoparticle-albumin-bound paclitaxel (Nab-P) over conventional taxanes in breast cancer patients is still controversial. We conducted a systematic review of studies to identify the optimal taxanes for selection in clinical practice. Methods: We enrolled studies if they enrolled adults (age ≥18) with breast cancer, compared Nab-P (at any dose) to conventional paclitaxel or docetaxel, provided information on survival data, the response rate, or adverse events, were randomized controlled trials, case-control studies, or cohort studies, and were published in English (including those published online, ahead of the print publication). Cochrane Collaboration tool and Newcastle-Ottawa scale were used for bias-risk assessment. Grading of recommendations assessment, development, and evaluation approach were adopted for the quality of evidence evaluation. The outcomes included the overall response rate, pathological complete response rate, progression-free survival, overall survival, allergic reaction, leukopenia, neutropenia, and sensory neuropathy. Results: A total of 20 eligible clinical studies comprising 11,046 patients were included in the analysis. No significant publication bias was observed based on a visual inspection of the funnel plots for progressionfree survival (PFS), and overall survival (OS). Compared to the conventional taxanes group (n=2,743), the Nab-P group (n=1,680) had a significantly higher ORR (RR =1.21, 95% CI: 1.07–1.37; P=0.003) and pCR (RR =1.33, 95% CI: 1.17–1.51; PDiscussion: The Nab-P in all stages of breast cancer patients had significantly better efficacy and tolerance than the conventional taxanes. Moreover, preventive strategies for reducing the incidence of Nab-P induced sensory neuropathy should be explored in future studies.
- 1 July 2022
- Published by AME Publishing Company in Annals of Palliative Medicine
- Vol. 11 (7) , 2382-2394
Open AccessEfficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis
Background: Long-term benefit of nanoparticle-albumin-bound paclitaxel (Nab-P) over conventional taxanes in breast cancer patients is still controversial. We conducted a systematic review of studies to identify the optimal taxanes for selection in clinical practice. Methods: We enrolled studies if they enrolled adults (age ≥18) with breast cancer, compared Nab-P (at any dose) to conventional paclitaxel or docetaxel, provided information on survival data, the response rate, or adverse events, were randomized controlled trials, case-control studies, or cohort studies, and were published in English (including those published online, ahead of the print publication). Cochrane Collaboration tool and Newcastle-Ottawa scale were used for bias-risk assessment. Grading of recommendations assessment, development, and evaluation approach were adopted for the quality of evidence evaluation. The outcomes included the overall response rate, pathological complete response rate, progression-free survival, overall survival, allergic reaction, leukopenia, neutropenia, and sensory neuropathy. Results: A total of 20 eligible clinical studies comprising 11,046 patients were included in the analysis. No significant publication bias was observed based on a visual inspection of the funnel plots for progressionfree survival (PFS), and overall survival (OS). Compared to the conventional taxanes group (n=2,743), the Nab-P group (n=1,680) had a significantly higher ORR (RR =1.21, 95% CI: 1.07–1.37; P=0.003) and pCR (RR =1.33, 95% CI: 1.17–1.51; PDiscussion: The Nab-P in all stages of breast cancer patients had significantly better efficacy and tolerance than the conventional taxanes. Moreover, preventive strategies for reducing the incidence of Nab-P induced sensory neuropathy should be explored in future studies.